Sponsor Pipeline

Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07203521 RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction Acute Large Hemispheric Infarction Stroke Not Yet Recruiting
Disease Areas
Stroke (1)
Get alerts when Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free